Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome (PCOS) can lead to Hair Loss through Hormonal Imbalances, particularly elevated levels of Androgens like Testosterone.
These androgens can disrupt the hair growth cycle, causing hair follicles to shrink and produce thinner, shorter hair. Additionally, high levels of insulin associated with PCOS can also contribute to hair loss by further increasing androgen production.
These androgens can disrupt the hair growth cycle, causing hair follicles to shrink and produce thinner, shorter hair. Additionally, high levels of insulin associated with PCOS can also contribute to hair loss by further increasing androgen production.
PRP TreatmentPlatelet-Rich Plasma (PRP) therapy and Polydioxanone (PDO) thread treatments offer promising solutions for managing hair loss in individuals with Polycystic Ovary Syndrome (PCOS). PRP therapy involves extracting a small amount of the patient’s blood, centrifuging it to concentrate the platelets, and then injecting the platelet-rich plasma into the scalp. These platelets contain growth factors that stimulate hair follicle activity, promote hair growth, and improve hair density.
|
20 year old with PCOS. Initial Photos and after 6 treatments of PRP.
|
57 year old with PCOS. Initial Photos and after 2 of 6 PRP treatments.
|
For individuals with PCOS-related hair loss, PRP therapy can be particularly effective due to its ability to address the underlying hormonal imbalances and promote healthy hair growth. The growth factors in PRP help to counteract the effects of elevated androgens, such as testosterone, which can disrupt the hair growth cycle in PCOS patients.
PDO Treatment
In addition to PRP therapy, PDO thread treatments offer another innovative approach to treating PCOS-related hair loss. PDO threads are dissolvable sutures made from a biocompatible material that is commonly used in cosmetic procedures. When strategically placed beneath the scalp, PDO threads provide support to weakened hair follicles and stimulate collagen production, resulting in firmer, healthier skin and improved hair growth.
Combination Treatment PRP & PDO Threads
Combining PRP therapy with PDO thread treatments can yield synergistic benefits for individuals with PCOS-related hair loss. PRP therapy addresses the hormonal imbalances that contribute to hair loss, while PDO threads provide structural support to the scalp and promote collagen production, creating an optimal environment for hair follicle regeneration and growth.
Moreover, both PRP therapy and PDO thread treatments are minimally invasive procedures with relatively low risk and minimal downtime, making them suitable options for individuals with PCOS who may be hesitant to undergo more invasive surgical interventions.
Overall, the combination of PRP therapy and PDO thread treatments offers a therapeutic approach to managing hair loss in individuals with PCOS. By addressing both the hormonal imbalances and structural deficiencies associated with PCOS-related hair loss, these treatments can help restore hair density, thickness, and overall scalp health, improving the confidence and quality of life for affected individuals.
Moreover, both PRP therapy and PDO thread treatments are minimally invasive procedures with relatively low risk and minimal downtime, making them suitable options for individuals with PCOS who may be hesitant to undergo more invasive surgical interventions.
Overall, the combination of PRP therapy and PDO thread treatments offers a therapeutic approach to managing hair loss in individuals with PCOS. By addressing both the hormonal imbalances and structural deficiencies associated with PCOS-related hair loss, these treatments can help restore hair density, thickness, and overall scalp health, improving the confidence and quality of life for affected individuals.
Regenera Activa Scalp Micrografts Using Your Own Stem Cells & Growth Factors
Regenera Activa leverages the power of our own scalp micrografts to activate and rejuvenate dormant hair follicles.
This treatment begins with the extraction of a small skin tissue sample from the patient's scalp, typically from the back of the head.This area is chosen because it usually remains unaffected by androgenetic alopecia, the most common form of hair loss, which predominantly affects the front and top of the scalp.
The collected tissue contains stem cells and growth factors essential for hair follicle health and regeneration. The tissue sample is then processed using a specialized device that isolates these regenerative cells. The resulting solution, rich in stem cells, growth factors, and progenitor cells, is injected into the scalp areas experiencing hair loss.
These regenerative cells enhance the health and function of existing hair follicles and stimulate the production of new hair
This treatment begins with the extraction of a small skin tissue sample from the patient's scalp, typically from the back of the head.This area is chosen because it usually remains unaffected by androgenetic alopecia, the most common form of hair loss, which predominantly affects the front and top of the scalp.
The collected tissue contains stem cells and growth factors essential for hair follicle health and regeneration. The tissue sample is then processed using a specialized device that isolates these regenerative cells. The resulting solution, rich in stem cells, growth factors, and progenitor cells, is injected into the scalp areas experiencing hair loss.
These regenerative cells enhance the health and function of existing hair follicles and stimulate the production of new hair
Nanoxidil Spectra CSFNANOXIDIL® 5% new generation version of the FDA Approved Minoxidil®. NANOXIDIL®5% a water-based product complexed with hair stimulating factors with improved efficacy but less adverse effects.
Water-Based Formula (non-greasy). Advanced Nanosome Delivery System®. This can be a successful option for women who suffer from hair loss from PCOS, for best results use with PRP Hair Treatments. |
|
References
1. "Androgenetic Alopecia in Women with Polycystic Ovary Syndrome: A Review" by International Journal of Dermatology (2011).
2. "Prevalence of Androgenetic Alopecia in Women with Polycystic Ovary Syndrome" by Journal of Dermatology (2012).
3. "Spironolactone in the Treatment of Hair Loss in Women with Polycystic Ovary Syndrome" by Journal of the American Academy of Dermatology (2014).
4. "Minoxidil for the Treatment of Androgenetic Alopecia in Women with Polycystic Ovary Syndrome" by Journal of Clinical and Aesthetic Dermatology (2016).
5. "The Role of Insulin Resistance in Hair Loss in Women with Polycystic Ovary Syndrome" by European Journal of Dermatology (2015).
6. "The Impact of Anti-Androgen Therapy in Women with PCOS and Androgenetic Alopecia" by Journal of the American Academy of Dermatology (2018).
7. "The Use of Oral Contraceptives in Women with Polycystic Ovary Syndrome and Hair Loss" by Obstetrics & Gynecology (2017).
8. "The Effect of Weight Loss on Hair Growth in Women with PCOS" by Journal of Clinical Endocrinology & Metabolism (2016).
9. "The Role of Genetic Factors in Androgenetic Alopecia in PCOS" by Journal of Investigative Dermatology (2019).
10. "Comparison of Finasteride and Spironolactone in the Treatment of Female Pattern Hair Loss Due to Polycystic Ovary Syndrome" by Dermatologic Therapy (2020).
2. "Prevalence of Androgenetic Alopecia in Women with Polycystic Ovary Syndrome" by Journal of Dermatology (2012).
3. "Spironolactone in the Treatment of Hair Loss in Women with Polycystic Ovary Syndrome" by Journal of the American Academy of Dermatology (2014).
4. "Minoxidil for the Treatment of Androgenetic Alopecia in Women with Polycystic Ovary Syndrome" by Journal of Clinical and Aesthetic Dermatology (2016).
5. "The Role of Insulin Resistance in Hair Loss in Women with Polycystic Ovary Syndrome" by European Journal of Dermatology (2015).
6. "The Impact of Anti-Androgen Therapy in Women with PCOS and Androgenetic Alopecia" by Journal of the American Academy of Dermatology (2018).
7. "The Use of Oral Contraceptives in Women with Polycystic Ovary Syndrome and Hair Loss" by Obstetrics & Gynecology (2017).
8. "The Effect of Weight Loss on Hair Growth in Women with PCOS" by Journal of Clinical Endocrinology & Metabolism (2016).
9. "The Role of Genetic Factors in Androgenetic Alopecia in PCOS" by Journal of Investigative Dermatology (2019).
10. "Comparison of Finasteride and Spironolactone in the Treatment of Female Pattern Hair Loss Due to Polycystic Ovary Syndrome" by Dermatologic Therapy (2020).